TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ATTOVIA THERAPEUTICS (ATTO) insider trades

ATTOVIA THERAPEUTICS (ATTO) insider trading activity (SEC Form 4). Over the trailing 90 days, ATTO insiders filed 6 purchases totalling $52.4M and 2 sales totalling $4.5M — net BUYING of $47.9M. Most recent filing: Aug 13, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
6
$52.4M
Sells (90d)
2
$4.5M
Net (90d)
+$47.9M
net buying
Most recent
Aug 13, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 10, 2026Venbio Global Strategic Fund Iv, L.P.10%P Purchase—$17.00$6.5Mfiling
Aug 7, 2026Redmile Group, LLC10%P Purchase—$17.00$10.2Mfiling
Aug 7, 2026Sanofi10%P Purchase—$17.00$5.1Mfiling
Aug 6, 2026Frazier Life Sciences Xi, L.P.10%P Purchase—$17.00$10.0Mfiling
Aug 13, 2026Walsh ColinDirS SaleOE—$21.28$2.3Mfiling
Aug 13, 2026Walsh ColinDirP Purchase—$17.58$10.3Mfiling
Aug 13, 2026Goldman Sachs Group IncFormer 10% OwnerS SaleOE—$21.28$2.3Mfiling
Aug 13, 2026Goldman Sachs Group IncFormer 10% OwnerP Purchase—$17.58$10.3Mfiling